We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Breakdown of the blood-brain barrier (BBB) may be an early biomarker of cognitive dysfunction, independent of amyloid or tau marker status, according to a study published online Jan. 14 in Nature Medicine....
French company CarThera has raised €9 million in its Series B funding round to help it develop ultrasound-based medical devices to treat brain disorders and overcome the challenges of the blood-brain barrier.
A new approach to getting drugs through the blood-brain barrier in Alzheimer's patients shows early promise, according to a study published online July 25 in Nature Communications. The research was published to coincide with the annual Alzheimer's Associa